2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Sales - EUR | 116.161 | - | 36.191 | 31.988 | 62.159 | 95.548 | 25.286 | 10.916 | 0 | 0 |
Total Income - EUR | 116.206 | - | 48.729 | 31.989 | 62.339 | 96.601 | 25.564 | 10.974 | 0 | 0 |
Total Expenses - EUR | 61.438 | - | 40.762 | 30.219 | 39.928 | 45.463 | 25.177 | 16.602 | 8.202 | 7.168 |
Gross Profit/Loss - EUR | 54.768 | - | 7.966 | 1.769 | 22.412 | 51.138 | 387 | -5.628 | -8.202 | -7.168 |
Net Profit/Loss - EUR | 45.650 | - | 7.479 | 1.449 | 21.788 | 50.172 | 157 | -5.738 | -8.202 | -7.168 |
Employees | 3 | - | 2 | 2 | 3 | 3 | 2 | 1 | 1 | 0 |
Check the financial reports for the company - Notabil Pharma Srl
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Check Financial Rating2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Fixed Assets | 1.955 | 9.150 | 16.289 | 24.206 | 17.078 | 2.745 | 6.515 | 12.210 | - | 33.689 |
Current Assets | 18.221 | - | 3.337 | 1.651 | 25.901 | 39.412 | 30.254 | 26.711 | 25.707 | 25.629 |
Inventories | 0 | - | 0 | 0 | 1.232 | 0 | 0 | 0 | 0 | 0 |
Receivables | 257 | - | 146 | 0 | 5 | 0 | 30.220 | 25.538 | 25.660 | 25.582 |
Cash | 17.964 | - | 3.190 | 1.651 | 24.665 | 39.412 | 34 | 1.173 | 46 | 46 |
Shareholders Funds | 45.882 | - | 7.711 | 1.677 | 22.012 | 50.391 | 49.593 | 42.755 | 34.686 | 27.413 |
Social Capital | 223 | - | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 |
Debts | 6.029 | - | 7.836 | 6.489 | 6.634 | 6.099 | 4.867 | 245 | 171 | 170 |
Income in Advance | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Exchange rate - RON | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 | 4.4821 |
Main CAEN | "4619 - 4619" | |||||||||
CAEN Financial Year | 4619 |
Subscriptions Financial Reports
You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.
Reports that can be accessed based on the subscription:
Get the contact details for any company and get in touch with it.